Scilex Holding (SCLX) Gross Margin (QoQ) (2022 - 2026)
Scilex Holding (SCLX) Gross Margin (QoQ) (2022 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 654.08 Bn | 633.32 Bn | 17.26 Bn |
| 2 | AbbVie | 470.80 Bn | 464.23 Bn | 12.70 Bn |
| 3 | Merck | 377.96 Bn | 370.82 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.49 Bn | 295.80 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.97 Bn | 253.07 Bn | 12.86 Bn |
| 6 | Amgen | 236.98 Bn | 222.99 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.41 Bn | 179.23 Bn | 6.22 Bn |
| 8 | Pfizer | 159.49 Bn | 147.79 Bn | 10.94 Bn |
| 9 | Gsk | 106.28 Bn | 102.11 Bn | 8.24 Bn |
| 10 | Scilex Holding | 39.28 Mn | -73.51 Mn | 3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 230.00 |
| Dec 31, 2025 | -2,248.00 |
| Sep 30, 2025 | 154.00 |
| Jun 30, 2025 | -538.00 |
| Mar 31, 2025 | 378.00 |
| Dec 31, 2024 | -536.00 |
| Sep 30, 2024 | 72.00 |
| Jun 30, 2024 | 846.00 |
| Mar 31, 2024 | -170.00 |
| Dec 31, 2023 | -6.00 |
| Sep 30, 2023 | -33.00 |
| Jun 30, 2023 | 74.00 |
| Mar 31, 2023 | 393.00 |
| Dec 31, 2022 | -612.00 |
| Sep 30, 2022 | -1,245.00 |
| Jun 30, 2022 | -250.00 |